The European Commission is consulting on the next implementing act in preparation for the forthcoming EU-level joint clinical assessments (JCAs) introduced under the 2022 Health Technology Assessment Regulation.
This draft act focuses on information exchange with the European Medicines Agency and is the third of six that will be the subject of a
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?